XJPX
6254
Market cap724mUSD
Dec 05, Last price
2,975.00JPY
1D
0.98%
1Q
-9.30%
Jan 2017
3,853.49%
IPO
369.43%
Name
Nomura Micro Science Co Ltd
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Nomura Micro Science Co., Ltd. engages in the design, installation, and sale of water treatment technologies in Japan, South Korea, Taiwan, China, and the United States. The company offers water treatment plants and equipment, including pure and ultra-pure water systems, pharmaceutical water production systems, wastewater treatment systems, and water reclamation systems. It also provides pretreatment systems, heat regenerative type membrane filtration equipment, coagulating sedimentation equipment, flocculation filtration, gravity filtration, and pressure filtration equipment, electrodeionization, ion exchange systems, reverse osmosis (RO) systems, vacuum and membrane degasifier, pure steam generators, package type purified water production systems, WFI production systems, ozone and hydrogen water production systems, and anti-static equipment. In addition, it offers return contamination monitor, H2O2 monitor, nuclepore membrane, filter cartridge, and piping and environmental materials; and site supply of pure water, and water analysis and evaluation services on a contract basis. The company serves electronics, pharmaceutical, biotechnology, food, environment and energy, and analysis industries. Nomura Micro Science Co., Ltd. was founded in 1969 and is headquartered in Atsugi, Japan.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | 2016‑03 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||